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Abstract
Background: People with dementia are at high risk for falls. However, little is known of the 
features causing falls in Alzheimer disease (AD). Our aim was to investigate how participants 
with AD fall. Methods: In the FINALEX (Finnish Alzheimer Disease Exercise Trial) study, par-
ticipants’ (n = 194) falls were followed up for 1 year by diaries kept by their spouses. Results: 
The most common reason for falls (n = 355) was stumbling (n = 61). Of the falls, 123 led to 
injuries, 50 to emergency department visits, and 13 to fractures. The participants without falls 
(n = 103) were younger and had milder dementia than those with 1 (n = 34) or ≥2 falls (n = 
57). Participants with a Mini Mental State Examination score of around 10 points were most 
prone to fall. In adjusted regression models, good nutritional status, good physical function-
ing, and use of antihypertensive medication (incident rate ratio [IRR] 0.68, 95% confidence 
interval [CI] 0.54–0.85) protected against falls, whereas fall history (IRR 2.71, 95% CI 2.13–
3.44), osteoarthritis, diabetes mellitus, chronic obstructive pulmonary disease, higher number 
of drugs, drugs with anticholinergic properties, psychotropics, and opioids (IRR 4.27, 95% CI 
2.92–6.24) were risk factors for falls. Conclusions: Our study provides a detailed account on 
how and why people with AD fall, suggesting several risk and protective factors.
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Introduction 
Risk factors for falls have been studied extensively in general older populations. Cognitive 
impairment and dementia are major risk factors for falls, causing approximately 60% of older 
persons with those disorders to fall annually [1, 2]. Other known risk factors are, for example, 
history of falls, muscle weakness, gait deficit and deficits, disability, visual deficit, arthritis, 
depression, older age, polypharmacy and especially psychotropic medications, and environ-
mental hazards [1, 3–7]. 
There are less studies on risk factors for falls among people with dementia, but older age, 
female gender, disability and history of falls have been associated with increased risk [8–10]. 
Furthermore, in a UK study, symptomatic orthostatic hypotension and symptoms of depres- 
sion were risk factors for falls, whereas higher levels of physical activity appeared to be 
protective [10]. More severe cognitive decline has been associated with falls [11, 12]. The use 
of psychotropics has been suggested to be a risk factor for falls [13, 14]. 
Although people with dementia are prone to falls, there has been a paucity of studies 
investigating prevention of their falls [4]. Only recently did a meta-analysis suggest that 
exercise has the potential to prevent falls among persons with known cognitive impairment 
[15]. 
To our knowledge, studies prospectively exploring the characteristics and consequences 
of falls among people with dementia are scarce. The FINALEX (Finnish Alzheimer Disease 
Exercise Trial) study was designed to investigate the efficacy of exercise among participants 
with Alzheimer disease (AD) [16]. The findings showed that the intervention groups bene-
fitted with respect to falls [16]. The participants with AD were assessed thoroughly at baseline 
for various risk factors [16, 17]. Furthermore, during the follow-up year, the participants’ 
spouses kept detailed diaries on falls and their characteristics, which is a highly sensitive 
method to accurately record falls [18]. 
The aim of this study was to investigate features of falls among persons with AD over a 
1-year follow-up. Furthermore, we tested various known risk factors on how they predict 
falls during the 1-year follow-up. 
Methods
The original FINALEX study (randomized controlled trial) comprised two active inter-
vention arms: home-based and group-based exercise intervention, both of which were super-
vised by physiotherapists and consisted of similar exercise components in approximately 1-h 
sessions held two times a week for 1 year. The control group received normal community care 
[16]. In this analysis, we investigate all participants (both intervention groups and control 
group) together to examine features behind the falls. We divided participants into three 
groups according to the number of falls: none, 1, and 2 or more falls during the 12-month 
study period. 
Participants 
In 2008, the Social Insurance Institution of Finland used its drug reimbursement register 
to recruit AD patients living with a spouse in the cities of Helsinki, Vantaa, or Espoo (n = 
1,264). Altogether 497 persons originally expressed an interest in participating. Study nurses 
managed to subsequently contact 390 persons, of whom 84 declined to participate and 96 did 
not fulfill the inclusion criteria: (1) speaking the Finnish language, (2) living with a spouse at 
home, (3) living in Helsinki, Vantaa, or Espoo, (4) aged ≥65 years, retired, (5) no difficult 
hemiplegia or diagnosed terminal disease, (6) walking independently with or without a 
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mobility aid, and (7) having at least one of the following signs of possible frailty: ≥1 fall during 
the previous year, unintentional weight loss, or decreased walking speed. A total of 210 
patients met our inclusion criteria and were included in the FINALEX study population. 
Eleven participants declined to participate and 5 died immediately after randomization 
resulting in 194 participants in this analysis. 
The Ethics Committee of Helsinki University Hospital approved the study protocol, and 
all patients provided informed consent. Spouses provided informed consent if patients had 
reduced judgment capacity. 
Of the 194 participants, 126 were in the intervention groups and 68 in the control group. 
A detailed description of the intervention has been published in a previous article [17]. Briefly, 
both intervention arms received 2 h exercising/week for 1 year supervised by physiothera-
pists: the home-based group in their own homes and the group-based exercise in day centers 
in groups of 10 participants. The control group received normal community care and was 
allowed to receive rehabilitation, including physiotherapy, in the public health care system. 
Clinical Measures 
We collected data on demographic factors (age, sex, education) at baseline. Participants’ 
nutritional status was assessed by the Mini Nutritional Assessment (MNA) [19], and their 
medical records served to confirm their medication and comorbidities; we then calculated 
the Charlson Comorbidity Index [20]. Cognitive status was evaluated by the Clinical Dementia 
Rating (CDR) scale [21] and the Mini Mental State Examination (MMSE) [22], and physical 
functioning was evaluated by the Functional Independence Measure (FIM) [23], the timed 
“Up and Go” test [24], and the Short Physical Performance Battery (SPPB) [25]. The SPPB 
includes tests of balance, walking speed, and rise from a chair; we investigated the balance 
and walking speed tests separately as well as the SPPB test itself [25]. Number of falls during 
the study is based on the fall diaries kept by the participants’ spouses. Fall diaries provided 
information on the dates and times of falls. The spouses evaluated the reason for a fall. In 
addition, they stated whether the fall led to injuries, an emergency department or doctor visit, 
or a fracture. A fall history was assessed by asking the spouses about participants’ falls in the 
year preceding the study. 
Statistical Analysis 
Statistical significance for the hypothesis of linearity was evaluated by using analysis of 
variance (ANOVA) or the Cochran-Armitage test. In case of violation of the assumptions (e.g., 
non-normality), a bootstrap-type test was used. Fall incidence rates (per 1,000 person-years) 
with 95% confidence intervals (CIs) were calculated assuming a Poisson distribution. 
Adjusted estimates of incidence rate ratios (IRRs) were calculated using Poisson regression 
models or negative binomial regression models when appropriate. The assumptions of over-
dispersion in the Poisson model were tested using the Lagrange multiplier test. A nonlinear 
relationship between the MMSE or number of drugs and incidence of falls was assessed by 
using Poisson regression, including quadratic terms. STATA 14.1, StataCorp LP (College 
Station, TX, USA) statistical package was used for the analyses. 
Results 
Baseline Characteristics of the Groups with None, One, and Two or More Falls 
The baseline characteristics are shown in Table 1 in three groups of fallers: none (n = 
103), 1 (n = 34), and 2 or more falls (n = 57). The proportion of participants receiving inter-
vention was higher in the groups with none or 1 fall than in those with 2 or more falls, but the 
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difference did not reach statistical significance. Falls increased with age and the nutritional 
status was better among those with none or 1 fall than among those with 2 or more falls. 
Systolic blood pressure was higher in those with none or 1 fall than in those with 2 or more 
falls. According to the CDR (score of 0.5–1, 2, or 3), the severity of dementia was higher among 
those with 2 or more falls than among those with none or 1 fall. The physical functioning 
according to FIM scores and SPPB score was higher in those with none or 1 fall than in those 
with 2 or more falls. There were more participants with vision problems among those with 2 
or more falls than among those with none or 1 fall. In the group of 2 or more falls, there were 
significantly more participants with previous fall(s) than in the other groups. No other signif-
icant differences were present in baseline characteristics with respect to the number of falls 
during the follow-up year. 
Description of Falls 
Altogether 355 falls occurred during the follow-up year. Half of them happened at midday. 
The other half took place equally during mornings, evenings, and at night. The most common 
reason for a fall was stumbling (n = 61), followed by dizziness (n = 37), and weakness of legs 
(n = 18). However, in most cases, the spouses were unable to state the reason for falling. Of 
355 falls, 123 led to injuries, 50 to emergency department visits, and 13 to fractures. 
Risk and Protective Factors for Falls 
Fall history during the preceding year was a strong risk factor for falls (IRR 2.71, 95% CI 
2.13–3.44). Figure 1 shows the associations of the MMSE score and number of drugs with the 
incidence of falls per person-year (adjusted for age, sex, and intervention). Figure 1a shows 





2 or more falls
(n = 57)
p for linearity
Intervention, n (%) 70 (71) 24 (71) 32 (56) 0.072
Mean age (SD), years 77 (5) 78 (6) 80 (4) 0.003
Male sex, n (%) 66 (64) 14 (41) 39 (68) 0.84
Education <8 years, n (%) 41 (40) 15 (44) 21 (37) 0.77
Mean BMI (SD) 25.9 (3.7) 25.5 (3.0) 25.0 (3.8) 0.30
Mean MNA (SD) 23 (2) 23 (1) 22 (3) 0.037
Mean blood pressure (SD), mm Hg
Systolic 153 (24) 154 (28) 143 (27) 0.016
Diastolic 77 (11) 79 (13) 74 (11) 0.19
Mean Charlson (SD) 2.6 (1.8) 2.7 (1.6) 2.9 (1.8) 0.22
Mean number of drugs (SD) 6.1 (3.2) 6.9 (3.0) 7.0 (3.8) 0.12
CDR, n (%) <0.001
0.5–1 44 (43) 12 (35) 10 (18)
2 47 (46) 17 (50) 31 (54)
3 12 (12) 5 (15) 16 (28)
Mean FIM total (SD) 92.6 (17.3) 92.0 (14.0) 77.2 (18.6) <0.001
Mean SPPB total (SD) 10.2 (2.1) 9.7 (1.8) 8.7 (2.4) <0.001
Vision problem, n (%) 6 (6) 2 (6) 9 (16) 0.042
Fall history, n (%) 32 (31) 38 (24) 35 (61) <0.001
SD, standard deviation; BMI, body mass index; MNA, Mini Nutritional Assessment; Charlson,  Charlson 
Comorbidity Index; CDR, Clinical Dementia Rating scale; FIM, Functional Independence Measure; SPPB, Short 
Physical Performance Battery.
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that participants with an MMSE score of around 10 points were the most prone to fall. Figure 
1b reveals that an increasing number of drugs was associated with a higher incidence of falls 
per person-year. 
Figure 2 presents the effects of physical features, diseases, and drugs on the IRRs of falls 
during follow-up (adjusted for age, sex, and intervention). A better score on all measured 
physical features (MNA [IRR 0.68, 95% CI 0.63–0.75], balance test [IRR 0.79, 95% CI 0.70–
0.88], walking speed [IRR 0.54, 95% CI 0.48–0.60], SPPB [IRR 0.62, 95% CI 0.56–0.69], Up and 
Go test [IRR 0.46, 95% CI 0.3–0.54], and FIM motor [IRR 0.49, 95% CI 0.45–0.54]) was asso-
ciated with a lower IRR of falls. Of the diseases, cancer (IRR 0.56, 95% CI 0.40–0.80) and 
hypertension (IRR 0.67, 95% CI 0.53–0.85) had a protective association with falls, whereas 
osteoarthritis (IRR 1.86, 95% CI 1.31–2.63), diabetes mellitus (IRR 1.59, 95% CI 1.23–2.06), 
and chronic obstructive pulmonary disease (COPD; IRR 2.18, 95% CI 1.33–3.56) increased the 
IRR. Antihypertensive medication (IRR 0.68, 95% CI 0.54–0.85) had a protective association, 
whereas drugs with anticholinergic properties (IRR 1.51, 95% CI 1.19–1.92), psychotropics 
(IRR 1.69, 95% CI 1.34–2.12), and opioids (IRR 4.27, 95% CI 2.92–6.24) increased the IRR. 
Discussion 
Our study gives a detailed description on how and why people with AD fall. In our study, 
traditional protective factors such as good physical functioning and nutritional status were 
associated with lower number of falls, whereas higher number of drugs, use of drugs with 
anticholinergic properties, psychotropics, and opioids, as well as osteoarthritis, diabetes, and 
COPD were positively associated with falls. An unexpected finding was that both hypertension 
and use of antihypertensive medication were protective factors for falls. People with very low 
or higher MMSE points were less prone to fall than those with an MMSE point of around 10. 
The FINALEX study has several strengths. All participants had a confirmed diagnosis of 
AD. Falls were assessed by fall diaries kept by spouses. Spousal caregivers continuously filled 
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Fig. 1. Mini Mental State Examination (MMSE) score (a) and number of drugs (b) in relation to the incidence 
of falls per person-years. 
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in diaries for falls. A diary has been found to be the best method to accurately record falls [18], 
supporting the reliability of our findings. We investigated the features behind falls in a 
prospective manner by dividing the participants into three groups (none, 1, and 2 or more 
falls) based on the falls they experienced during the study. 
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Fig. 2. Effects of physical features (a), diseases (b), and drugs (c) on incidence rate ratios (IRRs) of falls. SD, 
standard deviation; MNA, Mini Nutritional Assessment; SPPB, Short Physical Performance Battery; Balance, 
balance test of the SPPB; Walking speed, walking speed test of the SPPB; Up and Go, timed “Up and Go” test; 
FIM mot, motor part of the Functional Independence Measure; COPD, chronic obstructive pulmonary disease; 
CHD, coronary heart disease; DM, diabetes mellitus.
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This study also has several limitations. The external validity may be questioned since our 
participants were volunteers for a trial. In addition, all of the participants were living in their 
homes with their spousal caregivers in the community, and all were Caucasians. General-
ization of these results to other populations should therefore be made with appropriate 
caution. The FINALEX intervention decreased the number of falls in the intervention groups. 
Thus, the total number of falls in this study is lower than expected among people with AD. 
This may also have modified the features of their falls. However, our findings were adjusted 
for age, sex, and intervention considering risk factors for falls. Furthermore, to our knowledge, 
this is the first study to give a detailed description of falls among AD patients. The number of 
falls in the control group [16] is in line with previous studies performed among AD patients 
[10]. This high prevalence suggests that our caregivers have carefully recorded falls. 
Some significant differences were present in baseline characteristics between the groups 
of none, 1, and 2 or more falls. Persons in the group of 2 or more falls were older. They had 
poorer nutritional status according to the MNA. Also, their systolic blood pressure was lower 
than among those with none or only 1 fall. They had more problems with vision. Their stage 
of dementia was more severe according to the CDR. Also, their physical functioning according 
to the FIM and mobility limitations according to the SPPB were worse. These characteristics 
are similar to those found in earlier studies comparing fallers and nonfallers [8, 9, 14]. 
Our study is consistent with previous research suggesting that fall history is a risk factor 
for falls [8–10]. A previous study found that lower MMSE points (in the score range of 22–30) 
was a risk factor for falling in older persons with subtle cognitive impairment [11]. This is in 
accordance with our finding in those with higher MMSE scores. However, our study also 
suggests that persons with MMSE scores of around 10 points are the most prone to falls. 
Participants with extremely low scores fell less probably because they walk less. 
Our study’s findings concerning physical functioning, physical activity, and mobility limi-
tations are in line with earlier studies [3, 8, 10]. Higher MNA value served as a protective 
factor in our study, and previously MNA score has been found to be significantly higher among 
nonfallers than fallers [8]. 
Among older persons, polypharmacy and psychotropics have shown strong risk associa-
tions with falls [4]. Similar findings emerged in our study; higher numbers of drugs increased 
the risk of falls. Psychotropics were risk factors for falls, which is in line with other studies on 
people with dementia [13, 14]. An important finding here was that the use of opioids showed 
a high risk for falls. A previous systematic review had found one study in which opioids were 
associated with falls and one study without this association [26]. 
In contrast to earlier research [26, 27], our study found that both hypertension and anti-
hypertensive medication were protective factors against falls. A UK study had reported symp-
tomatic orthostatic hypotension as a risk factor [10]. The reasons behind our findings remain 
unclear. These participants with active diagnosis of hypertension and antihypertensives may 
reflect the same, robust participants having somewhat higher blood pressure whereas those 
with lower blood pressure may be those with more advanced dementia with a “terminal 
decline” in their blood pressure [28]. This hypothesis is supported by the fact that those with 
2 or more falls had lower blood pressure than those with less falls. However, a recent study 
among older hypertensive patients suggested that even the frailest patients benefit from anti-
hypertensive drugs [29]. Targeting blood pressure <120 mm Hg improved their prognosis 
without increasing falls [29]. 
Our study also found that COPD, diabetes mellitus, and osteoarthritis were risk factors 
for falls. Arthritis has previously been shown to be a risk factor among older persons [3]. A 
systematic review and meta-analysis found diabetes to be a risk factor for falls [30], in accor-
dance with our finding among persons with AD. In a study among older women, COPD was a 
risk factor for falls [31]. These diseases appear to also be risk factors in persons with AD. 
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Conclusion 
Individuals with AD are at high risk for falls, and our study provides a detailed overview 
on how and why people with AD fall. Results provided support for traditional risk and 
protective factors behind falls, but also some potentially important, new associations were 
observed. Antihypertensive drugs and opioids should be explored in future studies to 
determine whether interactions exist between characteristics of fallers and risk factors. 
Acknowledgment
This work was supported by the Social Insurance Institution of Finland; the Central Union 
for the Welfare of the Aged; the Sohlberg Foundation; and the King Gustaf V and Queen 
Victoria Foundation. The sponsors had no role in the study design, data analysis, or interpre-
tation of results, nor did they have a role in writing the report or in the decision to submit it 
for publication. The authors are independent researchers unassociated with the sponsors.
Disclosure Statement 
The authors have no conflicts of interests to declare. 
References
 1	 Tinetti	ME,	Speechley	M,	Ginter	SF:	Risk	factors	for	falls	among	elderly	persons	living	in	the	community.	N	Engl	
J Med 1988; 319: 1701–1707.
 2	 van	Dijk	PT,	Meulenberg	OG,	van	de	Sande	HJ,	Habbema	JD:	Falls	in	dementia	patients.	Gerontologist	1993; 33: 
200–204.
 3	 Guideline	for	the	prevention	of	falls	in	older	persons.	American	Geriatrics	Society,	British	Geriatrics	Society,	
and American Academy of Orthopaedic Surgeons Panel on Falls Prevention. J Am Geriatr Soc 2001; 49: 664–
672.
 4	 Panel	 on	Prevention	of	 Falls	 in	Older	Persons,	American	Geriatrics	 Society	 and	British	Geriatrics	 Society:	
Summary of the updated American Geriatrics Society/British Geriatrics Society clinical practice guideline for 
prevention of falls in older persons. J Am Geriatr Soc 2011; 59: 148–157.
 5	 Stalenhoef	 PA,	 Diederiks	 JP,	 Knottnerus	 JA,	 Kester	 AD,	 Crebolder	 HF:	 A	 risk	model	 for	 the	 prediction	 of	
recurrent falls in community-dwelling elderly: a prospective cohort study. J Clin Epidemiol 2002; 55: 1088–
1094.
 6	 Campbell	AJ,	Robertson	MC,	Gardner	MM,	Norton	RN,	Buchner	DM:	Psychotropic	medication	withdrawal	and	
a home-based exercise program to prevent falls: a randomized, controlled trial. J Am Geriatr Soc 1999; 47: 
850–853.
 7	 Leipzig	RM,	Cumming	RG,	Tinetti	ME:	Drugs	and	falls	in	older	people:	a	systematic	review	and	meta-analysis:	
I. Psychotropic drugs. J Am Geriatr Soc 1999; 47: 30–39.
 8	 Salva	A,	Roque	M,	Rojano	X,	Inzitari	M,	Andrieu	S,	Schiffrin	EJ,	Guigoz	Y,	Vellas	B:	Falls	and	risk	factors	for	falls	
in community-dwelling adults with dementia (NutriAlz trial). Alzheimer Dis Assoc Disord 2012; 26: 74–80.
 9	 Meuleners	LB,	Fraser	ML,	Bulsara	MK,	Chow	K,	Ng	JQ:	Risk	factors	for	recurrent	injurious	falls	that	require	
hospitalization for older adults with dementia: a population based study. BMC Neurol 2016; 16: 188.
10 Allan LM, Ballard CG, Rowan EN, Kenny RA: Incidence and prediction of falls in dementia: a prospective study 
in older people. PLoS One 2009; 4:e5521.
11 Gleason CE, Gangnon RE, Fischer BL, Mahoney JE: Increased risk for falling associated with subtle cognitive 
impairment: secondary analysis of a randomized clinical trial. Dement Geriatr Cogn Disord 2009; 27: 557–563.
12 Ohman H, Savikko N, Strandberg T, Kautiainen H, Raivio M, Laakkonen ML, Tilvis R, Pitkala KH: Effects of 
exercise on functional performance and fall rate in subjects with mild or advanced Alzheimer’s disease: 
secondary analyses of a randomized controlled study. Dement Geriatr Cogn Disord 2016; 41: 233–241.
13	 Kudo	Y,	Imamura	T,	Sato	A,	Endo	N:	Risk	factors	for	falls	in	community-dwelling	patients	with	Alzheimer’s	
disease and dementia with Lewy bodies: walking with visuocognitive impairment may cause a fall. Dement 
Geriatr Cogn Disord 2009; 27: 139–146.
203Dement Geriatr Cogn Disord ExtraE X T R A
Perttila et al.: Features behind Falls in Alzheimer Disease
www.karger.com/dee
© 2017 The Author(s). Published by S. Karger AG, BaselDOI: 10.1159/000477394
14 Horikawa E, Matsui T, Arai H, Seki T, Iwasaki K, Sasaki H: Risk of falls in Alzheimer’s disease: a prospective 
study. Intern Med 2005; 44: 717–721.
15	 Chan	WC,	Yeung	 JW,	Wong	CS,	Lam	LC,	Chung	KF,	Luk	 JK,	Lee	 JS,	Law	AC:	Efficacy	of	physical	exercise	 in	
preventing falls in older adults with cognitive impairment: a systematic review and meta-analysis. J Am Med 
Dir Assoc 2015; 16: 149–154.
16 Pitkala KH, Poysti MM, Laakkonen ML, Tilvis RS, Savikko N, Kautiainen H, Strandberg TE: Effects of the Finnish 
Alzheimer Disease Exercise Trial (FINALEX): a randomized controlled trial. JAMA Intern Med 2013; 173: 894–
901.
17 Pitkala KH, Raivio MM, Laakkonen ML, Tilvis RS, Kautiainen H, Strandberg TE: Exercise rehabilitation on 
home-dwelling patients with Alzheimer’s disease – a randomized, controlled trial. Study protocol. Trials 2010; 
11: 92.
18 Hannan MT, Gagnon MM, Aneja J, Jones RN, Cupples LA, Lipsitz LA, Samelson EJ, Leveille SG, Kiel DP: Opti-
mizing the tracking of falls in studies of older participants: comparison of quarterly telephone recall with 
monthly falls calendars in the MOBILIZE Boston study. Am J Epidemiol 2010; 171: 1031–1036.
19	 Guigoz	Y,	Lauque	S,	Vellas	BJ:	Identifying	the	elderly	at	risk	for	malnutrition.	The	Mini	Nutritional	Assessment.	
Clin Geriatr Med 2002; 18: 737–757.
20 Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longi-
tudinal studies: development and validation. J Chronic Dis 1987; 40: 373–383.
21 Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. Br J 
Psychiatry 1982; 140: 566–572.
22 Folstein MF, Folstein SE, McHugh PR: “Mini-mental state.” A practical method for grading the cognitive state 
of patients for the clinician. J Psychiatr Res 1975; 12: 189–198.
23 Pollak N, Rheault W, Stoecker JL: Reliability and validity of the FIM for persons aged 80 years and above from 
a multilevel continuing care retirement community. Arch Phys Med Rehabil 1996; 77: 1056–1061.
24 Podsiadlo D, Richardson S: The timed “up and go:” a test of basic functional mobility for frail elderly persons. 
J Am Geriatr Soc 1991; 39: 142–148.
25 Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, Scherr PA, Wallace RB: A short 
physical performance battery assessing lower extremity function: association with self-reported disability 
and prediction of mortality and nursing home admission. J Gerontol 1994; 49:M85–M94.
26 Hartikainen S, Lonnroos E, Louhivuori K: Medication as a risk factor for falls: critical systematic review. J 
Gerontol A Biol Sci Med Sci 2007; 62: 1172–1181.
27 Gangavati A, Hajjar I, Quach L, Jones RN, Kiely DK, Gagnon P, Lipsitz LA: Hypertension, orthostatic hypo-
tension, and the risk of falls in a community-dwelling elderly population: the maintenance of balance, inde-
pendent living, intellect, and zest in the elderly of Boston study. J Am Geriatr Soc 2011; 59: 383–389.
28 Benetos A, Bulpitt CJ, Petrovic M, Ungar A, Agabiti Rosei E, Cherubini A, Redon J, Grodzicki T, Dominiczak A, 
Strandberg T, Mancia G: An expert opinion from the European Society of Hypertension-European Union Geri-
atric Medicine Society working group on the management of hypertension in very old, frail subjects. Hyper-
tension 2016; 67: 820–825.
29 Williamson JD, Supiano MA, Applegate WB, Berlowitz DR, Campbell RC, Chertow GM, Fine LJ, Haley WE, 
Hawfield AT, Ix JH, Kitzman DW, Kostis JB, Krousel-Wood MA, Launer LJ, Oparil S, Rodriguez CJ, Roumie CL, 
Shorr RI, Sink KM, Wadley VG, Whelton PK, Whittle J, Woolard NF, Wright JT Jr, Pajewski NM; SPRINT Research 
Group: Intensive versus standard blood pressure control and cardiovascular disease outcomes in adults aged 
≥75 years: a randomized clinical trial. JAMA 2016; 315: 2673–2682.
30	 Yang	Y,	Hu	X,	Zhang	Q,	Zou	R:	Diabetes	mellitus	and	risk	of	falls	in	older	adults:	a	systematic	review	and	meta-
analysis. Age Ageing 2016; 45: 761–767.
31 Lawlor DA, Patel R, Ebrahim S: Association between falls in elderly women and chronic diseases and drug use: 
cross sectional study. BMJ 2003; 327: 712–717.
